Russia may become the world’s first country to approve coronavirus vaccine for public use in less than two weeks, according to reports. The coronavirus vaccine developed by Russian military and government researchers is currently undergoing phase 2 human trials.
According to media reports, Russian government officials may get the COVID-19 vaccine approved for public use by August 10. The vaccine developed by Moscow’s Gamaleya Institute will be approved for public use with frontline workers getting first dosage of the vaccine.
However, Russia still hasn’t released any scientific data of its coronavirus vaccine trials which raises questions regarding the efficacy and safety of the vaccine.
An international media had earlier reported that the Russian COVID-19 vaccine would be used parallely with phase 3 human trials and the country would vaccinate the frontline workers first who are at high risk of contracting COVID-19.
Also, according to reports, the vaccine distribution will be prioritised for elderly and those with health conditions. These people are expected to receive the vaccine just after frontline workers to reduce their risks of getting infected.
- Sikkim logs 40 new COVID-19 cases, 1 fresh fatality
- Fixed-wing flight services to remote towns of Arunachal Pradesh
- PM urges people to ensure no one is left out of vaccination’s ‘circle of safety’
- Sikkim districts to undergo nomenclature change: CM Golay
- How this social entrepreneur is championing love for voiceless animals
- Assam: 5 of 6 accused deny charges of instigating Gorukhuti violence